Session 1: Introduction to Novel, Therapeutic Approaches

This first session of the 3-part ACCC Knowledge Series, Chronic Lymphocytic Leukemia (CLL) Treatment Strategies, Sequencing, and Care Optimization, reviews novel, therapeutic approaches for CLL. LEARNING OBJECTIVES 1. Review evolving treatment landscape for CLL 2. Discuss optimal sequencing of therapies for CLL 3. Develop strategies to manage adverse events with novel therapies Faculty: Adam Kittai, MD Associate Professor of Medicine, CLL Clinical Research Leader Icahn School of Medicine at Mount Sinai Hospital New York, NY Jennifer Woyach, MD Professor of Medicine, Leukemia and Hematologic Malignancies Program Co-Leader The Ohio State University Columbus, OH